Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
- PMID: 28445728
- PMCID: PMC5413586
- DOI: 10.1016/j.celrep.2017.04.005
Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
Abstract
Surgery remains the most successful curative treatment for cancer. However, some patients with early-stage disease who undergo surgery eventually succumb to distant metastasis. Here, we show that in response to surgery, the lungs become more vulnerable to metastasis due to extracellular matrix remodeling. Mice that undergo surgery or that are preconditioned with plasma from donor mice that underwent surgery succumb to lung metastases earlier than controls. Increased lysyl oxidase (LOX) activity and expression, fibrillary collagen crosslinking, and focal adhesion signaling contribute to this effect, with the hypoxic surgical site serving as the source of LOX. Furthermore, the lungs of recipient mice injected with plasma from post-surgical colorectal cancer patients are more prone to metastatic seeding than mice injected with baseline plasma. Downregulation of LOX activity or levels reduces lung metastasis after surgery and increases survival, highlighting the potential of LOX inhibition in reducing the risk of metastasis following surgery.
Keywords: breast cancer; host response; hypoxia; lysyl oxidase; metastasis; pre-metastatic niche; surgery.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.
Figures
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5413586/bin/fx1.gif)
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5413586/bin/gr1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5413586/bin/gr2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5413586/bin/gr3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5413586/bin/gr4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5413586/bin/gr5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5413586/bin/gr6.gif)
Similar articles
-
T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy.Cancer Res. 2022 Jan 15;82(2):278-291. doi: 10.1158/0008-5472.CAN-21-1012. Epub 2021 Oct 19. Cancer Res. 2022. PMID: 34666995 Free PMC article.
-
Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy.Pharmacol Ther. 2020 Nov;215:107633. doi: 10.1016/j.pharmthera.2020.107633. Epub 2020 Jul 18. Pharmacol Ther. 2020. PMID: 32693113 Review.
-
Lysyl oxidase in cancer inhibition and metastasis.Cancer Lett. 2018 Mar 28;417:174-181. doi: 10.1016/j.canlet.2018.01.006. Epub 2018 Jan 5. Cancer Lett. 2018. PMID: 29309816 Review.
-
LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer.Oncotarget. 2017 Feb 14;8(7):11977-11989. doi: 10.18632/oncotarget.14450. Oncotarget. 2017. PMID: 28060764 Free PMC article.
-
Lysyl oxidase is essential for hypoxia-induced metastasis.Nature. 2006 Apr 27;440(7088):1222-6. doi: 10.1038/nature04695. Nature. 2006. Retraction in: Nature. 2020 Mar;579(7799):456. doi: 10.1038/s41586-020-2112-4. PMID: 16642001 Retracted.
Cited by
-
Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy.J Transl Med. 2024 Apr 24;22(1):382. doi: 10.1186/s12967-024-05199-3. J Transl Med. 2024. PMID: 38659022 Free PMC article. Review.
-
Extracellular vesicle-mediated pre-metastatic niche formation via altering host microenvironments.Front Immunol. 2024 Mar 1;15:1367373. doi: 10.3389/fimmu.2024.1367373. eCollection 2024. Front Immunol. 2024. PMID: 38495881 Free PMC article. Review.
-
Fibroblasts: invigorated targets in pre-metastatic niche formation.Int J Biol Sci. 2024 Jan 21;20(3):1110-1124. doi: 10.7150/ijbs.87680. eCollection 2024. Int J Biol Sci. 2024. PMID: 38322116 Free PMC article. Review.
-
LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer.J Bone Oncol. 2024 Jan 5;44:100522. doi: 10.1016/j.jbo.2024.100522. eCollection 2024 Feb. J Bone Oncol. 2024. PMID: 38283827 Free PMC article.
-
Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?Clin Exp Med. 2024 Jan 17;24(1):2. doi: 10.1007/s10238-023-01278-9. Clin Exp Med. 2024. PMID: 38231464 Free PMC article. Review.
References
-
- Adini A., Fainaru O., Udagawa T., Connor K.M., Folkman J., D’Amato R.J. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo. J. Immunol. Methods. 2009;342:78–81. - PubMed
-
- Ando N., Iizuka T., Ide H., Ishida K., Shinoda M., Nishimaki T., Takiyama W., Watanabe H., Isono K., Aoyama N., Japan Clinical Oncology Group Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J. Clin. Oncol. 2003;21:4592–4596. - PubMed
-
- Barcellos-Hoff M.H., Park C., Wright E.G. Radiation and the microenvironment - tumorigenesis and therapy. Nat. Rev. Cancer. 2005;5:867–875. - PubMed
-
- Barker H.E., Cox T.R., Erler J.T. The rationale for targeting the LOX family in cancer. Nat. Rev. Cancer. 2012;12:540–552. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical